LitAlert ~~

    • Stable CDK12 knock-out ovarian cancer cells do not show increased sensitivity to cisplatin and PARP inhibitor treatment.
    • Chilà R, Guffanti F, Chiappa M, Panini N, Conconi D, Rinaldi A, Cascione L, Bertoni F, Fratelli M, Damia G.
    • Front Oncol. 2022 May 24;12:903536. doi: 10.3389/fonc.2022.903536.
    • Role of EMT in the DNA damage response, double-strand break repair pathway choice and its implications in cancer treatment.
    • Moyret-Lalle C, Prodhomme MK, Burlet D, Kashiwagi A, Petrilli V, Puisieux A, Seimiya H, Tissier A.
    • Cancer Sci. 2022 May 9. doi: 10.1111/cas.15389. Epub ahead of print.